OsseoLabs, founded in 2021, is headquartered in Thailand and seeks to redefine surgical procedures by merging 3D-printing, AI, and biomechanics. With a strong emphasis on maxillofacial and orthopedic surgeries, the company aims to deliver bespoke medical devices and personalized surgical solutions to meet individual anatomical requirements.
The burgeoning startup specializes in providing precision and customization, critical elements in achieving successful healthcare outcomes. The company's cutting-edge technological integration places it at the forefront of medical innovation.
OsseoLabs recently secured a $1.40M Seed investment as of 01 May 2023, underscoring investor confidence in its innovative approach. Although specific investors have not been disclosed, the capital injection points toward a growing interest in early-stage health tech propositions, affirming OsseoLabs' potential for scalable growth in the precision surgery market.